{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:34Z","timestamp":1777870414649,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s40620-015-0180-6","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T02:38:40Z","timestamp":1424659120000},"page":"633-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial"],"prefix":"10.1093","volume":"28","author":[{"given":"Mario","family":"Carmellini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Russ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,2,24]]},"reference":[{"key":"180_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2008.00859.x","volume":"22","author":"SM Flechner","year":"2008","unstructured":"Flechner SM, Kobashigawa J, Klintmalm G (2008) Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 22:1\u201315","journal-title":"Clin Transplant"},{"key":"180_CR2","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1681\/ASN.2010111160","volume":"22","author":"A Sharif","year":"2011","unstructured":"Sharif A, Shabir S, Chand S, Cockwell P, Ball S, Borrows R (2011) Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation. J Am Soc Nephrol 22:2107\u20132118","journal-title":"J Am Soc Nephrol"},{"key":"180_CR3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MOT.0b013e328359886a","volume":"17","author":"R Ruiz","year":"2012","unstructured":"Ruiz R, Klintmalm GB (2012) Renal-sparing regimens employing new agents. Curr Opin Organ Transplant 17:619\u2013625","journal-title":"Curr Opin Organ Transplant"},{"key":"180_CR4","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s11255-014-0783-1","volume":"46","author":"L Su","year":"2014","unstructured":"Su L, Tam N, Deng R, Chen P, Li H, Wu L (2014) Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis. Int Urol Nephrol 46:2035\u20132044","journal-title":"Int Urol Nephrol"},{"key":"180_CR5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/TP.0b013e31825b411c","volume":"94","author":"C Gurk-Turner","year":"2012","unstructured":"Gurk-Turner C, Manitpisitkul W, Cooper M (2012) A comprehensive review of everolimus clinical reports: a new mammalian target of rapamycin inhibitor. Transplantation 94:659\u2013668","journal-title":"Transplantation"},{"key":"180_CR6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40620-014-0103-y","volume":"27","author":"G Zaza","year":"2014","unstructured":"Zaza G, Granata S, Tomei P, Masola V, Gambaro G, Lupo A (2014) mTOR inhibitors and renal allograft: Yin and Yang. J Nephrol 27:495\u2013506","journal-title":"J Nephrol"},{"key":"180_CR7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(10)62318-5","volume":"377","author":"K Budde","year":"2011","unstructured":"Budde K, Becker T, Arns W, Sommerer C, Reinke P, Eisenberger U, Kramer S, Fischer W, Gschaidmeier H, Pietruck F, ZEUS Study Investigators (2011) Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet 377:837\u2013847","journal-title":"Lancet"},{"key":"180_CR8","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/j.1600-6143.2012.04162.x","volume":"12","author":"L Mj\u00f6rnstedt","year":"2012","unstructured":"Mj\u00f6rnstedt L, S\u00f8rensen SS, von M\u00fchlen Zur B, Jespersen B, Hansen JM, Bistrup C, Andersson H, Gustafsson B, Undset LH, Fagertun H, Solbu D, Holdaas H (2012) Improved renal function after early conversion from a calcineurin inhibitor to everolimus: a randomized trial in kidney transplantation. Am J Transplant 12:2744\u20132753","journal-title":"Am J Transplant"},{"key":"180_CR9","doi-asserted-by":"crossref","unstructured":"Budde K, Sommerer C, Rath T, Reinke P, Haller H, Witzke O, Suwelack B, Baeumer D, Sieder C, Porstner M, Arns W (2014) Renal function to 5\u00a0years after late conversion of kidney transplant patients to everolimus: a randomized trial. J Nephrol [Epub ahead of print]","DOI":"10.1007\/s40620-014-0134-4"},{"key":"180_CR10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1600-6143.2010.03129.x","volume":"10","author":"H Tedesco Silva Jr","year":"2010","unstructured":"Tedesco Silva H Jr, Cibrik D, Johnston T, Lackova E, Mange K, Panis C, Walker R, Wang Z, Zibari G, Kim YS (2010) Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients. Am J Transplant 10:1401\u20131413","journal-title":"Am J Transplant"},{"key":"180_CR11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2004.00389.x","volume":"4","author":"S Vitko","year":"2004","unstructured":"Vitko S, Tedesco H, Eris J, Pascual J, Whelchel J, Magee JC, Campbell S, Civati G, Bourbigot B, Alves Filho G, Leone J, Garcia VD, Rigotti P, Esmeraldo R, Cambi V, Haas T, Jappe A, Bernhardt P, Geissler J, Cretin N (2004) Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies. Am J Transplant 4:626\u2013635","journal-title":"Am J Transplant"},{"key":"180_CR12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/TP.0b013e318166927b","volume":"85","author":"L Chan","year":"2008","unstructured":"Chan L, Greenstein S, Hardy MA, Hartmann E, Bunnapradist S, Cibrik D, Shaw LM, Munir L, Ulbricht B, Cooper M, CRADUS09 Study Group (2008) Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. Transplantation 85:821\u2013826","journal-title":"Transplantation"},{"key":"180_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/TP.0b013e3181aa7d87","volume":"88","author":"L Albano","year":"2009","unstructured":"Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefran\u00e7ois N, Charpentier B, Blanc AS, Di Giambattista F, Dantal J, RAD A2420 Study Group (2009) Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus. Transplantation 88:69\u201376","journal-title":"Transplantation"},{"key":"180_CR14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"180_CR15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/TP.0b013e3182848e03","volume":"95","author":"D Cibrik","year":"2013","unstructured":"Cibrik D, Silva HT Jr, Vathsala A, Lackova E, Cornu-Artis C, Walker RG, Wang Z, Zibari GB, Shihab F, Kim YS (2013) Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24\u00a0months in renal transplantation. Transplantation 95:933\u2013942","journal-title":"Transplantation"},{"key":"180_CR16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/TP.0b013e3182a486f5","volume":"96","author":"K Melancon","year":"2013","unstructured":"Melancon K, Mulgaonkar SP, Delcoro C, Wiland A, McCague K, Shihab FS (2013) Outcomes in ethnic minority renal transplant recipients receiving everolimus versus mycophenolate: comparative risk assessment results from a pooled analysis. Transplantation 96:1073\u20131081","journal-title":"Transplantation"},{"key":"180_CR17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1523-1755.2000.00235.x","volume":"58","author":"H Boom","year":"2000","unstructured":"Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC (2000) Delayed graft function influences renal function, but not survival. Kidney Int 58:859\u2013866","journal-title":"Kidney Int"},{"key":"180_CR18","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/ndt\/gfl042","volume":"21","author":"I Quiroga","year":"2006","unstructured":"Quiroga I, McShane P, Koo DD, Gray D, Friend PJ, Fuggle S, Darby C (2006) Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transpl 21:1689\u20131696","journal-title":"Nephrol Dial Transpl"},{"key":"180_CR19","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.1111\/ctr.12029","volume":"26","author":"D Jayaram","year":"2012","unstructured":"Jayaram D, Kommareddi M, Sung RS, Luan FL (2012) Delayed graft function requiring more than one-time dialysis treatment is associated with inferior clinical outcomes. Clin Transplant 26:E536\u2013E543","journal-title":"Clin Transplant"},{"key":"180_CR20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ndt\/gfn667","volume":"24","author":"SG Yarlagadda","year":"2009","unstructured":"Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR (2009) Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 24:1039\u20131047","journal-title":"Nephrol Dial Transplant"},{"key":"180_CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-6143.2005.01198.x","volume":"6","author":"JL Gore","year":"2006","unstructured":"Gore JL, Pham PT, Danovitch GM, Wilkinson AH, Rosenthal JT, Lipshutz GS, Singer JS (2006) Obesity and outcome following renal transplantation. Am J Transplant 6:357\u2013363","journal-title":"Am J Transplant"},{"key":"180_CR22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2215\/CJN.04681107","volume":"3","author":"EH Cole","year":"2008","unstructured":"Cole EH, Johnston O, Rose CL, Gill JS (2008) Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol 3:814\u2013821","journal-title":"Clin J Am Soc Nephrol"},{"key":"180_CR23","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","volume":"11","author":"TB Dunn","year":"2011","unstructured":"Dunn TB, Noreen H, Gillingham K, Maurer D, Ozturk OG, Pruett TL, Bray RA, Gebel HM, Matas AJ (2011) Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant 11:2132\u20132143","journal-title":"Am J Transplant"},{"key":"180_CR24","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1600-6143.2009.03009.x","volume":"10","author":"PY Fan","year":"2010","unstructured":"Fan PY, Ashby VB, Fuller DS, Boulware LE, Kao A, Norman SP, Randall HB, Young C, Kalbfleisch JD, Leichtman AB (2010) Access and outcomes among minority transplant patients, 1999\u20132008, with a focus on determinants of kidney graft survival. Am J Transplant 10:1090\u20131107","journal-title":"Am J Transplant"},{"key":"180_CR25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/ndt\/gfp530","volume":"25","author":"FL Ng","year":"2010","unstructured":"Ng FL, Holt DW, Chang RWS, Macphee IA (2010) Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups. Nephrol Dial Transplant 25:628\u2013634","journal-title":"Nephrol Dial Transplant"},{"key":"180_CR26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/SLA.0b013e3181f65c7d","volume":"252","author":"SG Tullius","year":"2010","unstructured":"Tullius SG, Tran H, Guleria I, Malek SK, Tilney NL, Milford E (2010) The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann Surg 252:662\u2013674","journal-title":"Ann Surg"},{"key":"180_CR27","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1681\/ASN.V1271538","volume":"12","author":"J Fijter De","year":"2001","unstructured":"De Fijter J, Mallat MJ, Doxiadis II, Ringers J, Rosendaal FR, Claas FH, Paul LC (2001) Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 12:1538\u20131546","journal-title":"J Am Soc Nephrol"},{"key":"180_CR28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/TP.0b013e3181a24073","volume":"87","author":"C S\u00fcsal","year":"2009","unstructured":"S\u00fcsal C, D\u00f6hler B, Sadeghi M, Ovens J, Opelz G (2009) HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a Collaborative Transplant Study report. Transplantation 87:1367\u20131371","journal-title":"Transplantation"},{"key":"180_CR29","doi-asserted-by":"crossref","first-page":"E428","DOI":"10.1111\/j.1399-0012.2012.01654.x","volume":"26","author":"WH Lim","year":"2012","unstructured":"Lim WH, Chadban SJ, Clayton P, Budgeon CA, Murray K, Campbell SB, Cohney S, Russ GR, McDonald SP (2012) Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clin Transplant 26:E428\u2013E437","journal-title":"Clin Transplant"},{"key":"180_CR30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.tp.0000255583.34329.dd","volume":"83","author":"CM \u00d8ien","year":"2007","unstructured":"\u00d8ien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007) Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation 83:600\u2013606","journal-title":"Transplantation"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-015-0180-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0180-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:47Z","timestamp":1777564667000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/28\/5\/633\/8372181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,24]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1007\/s40620-015-0180-6","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,24]]}}}